2 days ago
Base Salary
$131k - $246k/yr
Responsibilities
- Engineer features from biosignal data and train machine learning models to detect high-risk coronary artery disease.
- Own data quality and curation for clinical study datasets from raw site exports through analysis-ready dataframes.
- Run rigorous model evaluations and write verification, validation, and regulatory documentation for a diagnostic medical device.
- Collaborate with clinical operations, product, and engineering teams to support clinical studies and define ML system requirements.
- Deploy machine learning models into production in a cloud environment.
Requirements
- Master’s or PhD in biomedical engineering, biophysics, machine learning, or a related field.
- Five years of industry experience with biomedical signal processing and machine learning.
- Experience applying classical machine learning in data-scarce environments and shipping a commercial product.
- Expertise with Python data science tools including NumPy, SciPy, scikit-learn, and PyTorch, plus familiarity with SQL and AWS.
- Working knowledge of ECG, cardiac electrophysiology, and quantitative biomedical research methods for diagnostics.
- Preferred qualifications include cardiac or neurological medical device experience; FDA 510(k), SaMD, IEC 62304, ISO 14971, and Good Machine Learning Practice experience; deep learning experience; strong biomedical signal processing or clinical publication history; LLM coding assistant and agentic tool experience; and MCG, biomagnetic data, or multichannel sensor array experience.
Benefits
- Competitive base salary commensurate with experience, plus equity and performance-based incentives.
- Comprehensive health, dental, and vision insurance.
- 401(k) with company match and generous parental leave.
- Flexible hybrid work arrangements and generous paid time off.
- Exposure to CHIPS Act-funded programs, senior scientific and executive leadership, mentorship, and dedicated learning budgets.
Categories
About SandboxAQ
SandboxAQ builds enterprise software that combines AI with quantum technologies for use cases such as cryptography and cybersecurity, molecular simulation in life sciences, and navigation via quantum sensing. It sells B2B platforms and services, including crypto-agility and post-quantum security offerings, to customers in regulated and research-heavy sectors. Founded in 2021 and headquartered in Palo Alto, the company emerged from Alphabet as an independent entity in 2022.
